medigraphic.com
ISSN 1560-4381 (Print)

2019, Number 2

<< Back Next >>

Correo Científico Médico 2019; 23 (2)

Photodynamic therapy biological action on bladder cancer

Sagué DK, Sagué LJ, Doimeadios RZ, Gómez LB, Díaz AMT

Language: Spanish
References: 32
Page:
PDF size: 114.81 Kb.


ABSTRACT

Photodynamic Therapy (PDD) is a tumor cell destruction treatment, harmless for surrounding normal tissues. It is based on photosensitizing components combined with different types of lights (LED lamps), which generate a big amount of energy with specific wavelengths. It is applied over several genitourinary tumors. It shows the 6th place of worldwide frequency with predominant appearance on bladder neoplasm superficial tumors. Photodynamic diagnosis is superior to white light cystoscopy, according to clinical trials comparisons and individual statistics for pathology detection. Before creating clinical definition guidelines, current data must be carefully analyzed for clearer treatment stages such as: tumor progression, disease-free interval and survival.


REFERENCES

  1. Ferriols Lisart F, Pitarch Molina J. Principios de la fototerapia y su aplicación en el paciente oncológico. Farm Hosp.2004 [citado 20 jun 2017]; 28(3):205-213. Disponible en: https://www.elsevier.es/es-revistafarmacia- hospitalaria-121-articulo-principios-fototerapia-su-aplicacion-el- 13118638

  2. Inoue K, Matsuyama H, Fujimoto K, Hirao Y, Watanabe H, Ozono S,et al. The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent lightguided cystoscopy after oral administration of 5-aminolevulinic acid (5- ALA).Photodiagnosis Photodyn Ther. 2016[citado 20 jun 2017]; 13:91-96. Disponible en: https://doi.org/10.1016/j.pdpdt.2015.12.011

  3. Esserman LJ, Thompson IM, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement.JAMA. 2013 [citado 20 jun 2017];310(8):797-798.Disponible en:https://jamanetwork.com/journals/jama/fullarticle/1722196? __hsfp=1773666937&__hssc=13887208.1.1471737600051&__hstc=1388 7208.b0149eea46c019b2428a32d37a2daa1a.1471737600048.147173760 0050.1471737600051.2

  4. Kamat AM, Cookson M, Witjes JA, Stenzl A, Grossman HB. The impact of blue light cystoscopy with hexaminolevulinate (HAL) on progression of bladder cancer: a new analysis. Bladder Cancer. 2016 [citado 20 jun 2017];2(2): 273–278. Disponible en: https://content.iospress.com/articles/bladder-cancer/blc160048

  5. Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2016. EurUrol. 2017 [citado 20 jun 2017]; 71 (3):447–461. Disponible en: https://doi.org/10.1016/j.eururo.2016.05.041

  6. Marien A, Rock A, Maadarani KE, Francois C, Gosset P, Mauroy B, et al. Urothelial Tumors and Dual-Band Imaging: A New Concept in Confocal Laser Endomicroscopy. J Endourol. 2017[citado 15 jun 2017]; 31(5):538- 544. Disponible en: https://doi.org/10.1089/end.2016.0892

  7. van Rhijn BW, Catto JW, Goebell PJ, Knüchel R, Shariat SF, van der Poel HG, et al. Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice. Urol Oncol. 2014[citado 15 jun 2017]; 32(7): 1078–1087. Disponible en: https://doi.org/10.1016/j.urolonc.2014.07.002

  8. Min CG, Ferreira PJO, Pinto da Silva L.Theoretically obtained insight into the mechanism and dioxetanone species responsible for the singlet chemiexcitation of Coelenterazine.J PhotochemPhotobiol B. 2017[citado 10 jun 2017]; 174:18-26. Disponible en: https://doi.org/10.1016/j.jphotobiol.2017.07.012

  9. Salazar Gomis M. Síntesis y caracterización de Ftalocianinas de silicio como precursores de fármacos para terapia fotodinámica contra el cáncer. [Tesis]. Barcelona. Universidad Miguel Hernández de Elche; 2016.

  10. Pino Pinto JP. Incorporación de un fotosensibilizador porfirínico en una matriz biopolimérica para su posible uso en terapia fotodinámica. [Tesis].Santiago de Chile: Escuela de Química y Farmacia, Facultad de Ciencias, Universidad Austral de Chile; 2013.

  11. Arredondo Espinoza E, López Cortina S, Balderas Rentería I. Synthesis and Photodynamic Activity of 5,10,15-Tris(p-chlorophenyl)-20-(2-hydroxy- 3-methoxyphenyl)-21H,23H-porphyrin. J Mexican Chem Soc. 2014 [citado 12 jun 2018]; 58(4): 369-373. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1870- 249X2014000400001&lng=es

  12. Roblero Bartolón GV, Ramón Gallegos E.Uso de nanopartículas (NP) en la terapia fotodinámica (photodynamic therapy [PDT]) contra el cáncer. Gac Med Mexico. 2015[citado 15 jun 2017]; 151(1):85-98. Disponible en: www.medigraphic.com/pdfs/gaceta/gm-2015/gm151l.pdf

  13. O’Connor AE, Gallagher WM, Byrne AT. Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy. Photochemical and Photobiology.2009 [citado 15 jun 2017]; 85(5): 1053–1074. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1751-1097.2009.00585.x

  14. Citarella D, Quiroga Matamoros W, Fernandez F, Patiño I, Estrada A. Guía de manejo en cáncer vesical. RevUrol Colombiana. 2016 [citado 15 jun 2017]; 25(2):154-168. Disponible en: http://www.redalyc.org/articulo.oa?id=149146287015

  15. Zou Z, Chang H, Li H, Wang S. Induction of reactive oxygen species: an emerging approach for cancer therapy .Apoptosis. 2017[citado 20 jun 2017]; 22(11):1321-1335. Disponible en: https://link.springer.com/article/10.1007/s10495-017-1424-9

  16. Sánchez V, Romero MP, Pratavieira S, Costa C. Physiological considerations acting on triplet oxygen for explicit dosimetry in photodynamic therapy .Photodiagnosis Photodyn Ther. 2017[citado 20 jun 2017];19:298-303. Disponible en: https://doi.org/10.1016/j.pdpdt.2017.07.008

  17. Uranga J, Matxain JM, Lopez X, Ugalde JM, Casanova D. Photosensitization mechanism of Cu(ii) porphyrins. Phys ChemChem Phys. 2017[citado 20 junio 2017]; 19(31):20533-20540. Disponible en: https://pubs.rsc.org/en/content/articlelanding/2017/cp/c7cp03319b/unauth #!divAbstract

  18. Li L, Wang H, Wang H, Li L, Wang P, Wang X, Liu Q.Interaction and oxidative damage of DVDMS to BSA: a study on the mechanism of photodynamic therapy -induced cell death.Sci Rep. 2017[citado 20 jun 2017]; 7: 43324. Disponible en: https://www.nature.com/articles/srep43324.pdf

  19. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015[citado 20 jun 2017]; 136(5):359-386. Disponible en: https://doi.org/10.1002/ijc.29210

  20. Inoue K, Anai S, Fujimoto K, Hirao Y, Furuse H, Kai F, et al. Oral 5- aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.Photodiagnosis Photodyn Ther. 2015[citado 20 jun 2017]; 12(2):193-200. Disponible en: https://doi.org/10.1016/j.pdpdt.2015.03.008

  21. Recchia A, Gerace C, Era S, Doria S, Di Ponzio G, Teruzzi C. VP130 Burden Of Illness For Urothelial Bladder Cancer (UBC) In Italy. InternJ TechnolAssessmHealth Care. 2017 [citado 15 jun 2018]; 33(S1):208.Disponible en: https://doi.org/10.1017/S0266462317003798

  22. Chen WH, Luo GF, Qiu WX, Lei Q, Liu LH, Wang SB, et al. Mesoporous silica-based versatile theranostic nanoplatform constructed by layer-bylayer assembly for excellent photodynamic/chemo therapy.Biomaterials.2017[citado 15 jun 2018]; 117: 54-65. Disponible en: https://doi.org/10.1016/j.biomaterials.2016.11.057

  23. Nakai Y, Tatsumi Y, Miyake M, Kuwada M, Onishi S, et al. Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer. PhotodiagnosisPhotodyn Ther. 2016[citado 15 jun 2018]; 13:225–232. Disponible en: https://doi.org/10.1016/j.pdpdt.2015.07.174

  24. Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, et al. Hexaminolevulinate blue-light cystoscopy in nonmuscleinvasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014[citado 15 jun 2018];11(10): 589–596. Disponible en: https://www.nature.com/articles/nrurol.2014.245

  25. Arias Sánchez A. Nanofibras poliméricas con ácido 5aminolevulínico: preparación, caracterización y estudio de liberación in vitro[Tesis]. Alicante: Sant Joan d’Alacant, España; 2015.

  26. Miyake M, Gotoh D, Shimada K, Tatsumi Y, Nakai Y, Anai S, et al. Exploration of risk factors predicting outcomes for primary T1 high‐grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: long‐term follow‐up experience at a single institute. Int J Urol. 2015[citado 12 jun 2017]; 22 (6): 541–547.Disponible en: https://doi.org/10.1111/iju.12749

  27. Lin T, Zhao X, Zhao S, Yu H, Cao W, Chen W, et al. O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia. Theranostics. 2018[citado 12 jun 2018]; 8(4):990- 1004. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817106

  28. Takamoto D, Kawahara T, Ohtake S, Mochizuki T, Kuroda S, Nakaigawa N, et al. Fluorescent Light-Guided Cystoscopy with 5-ALA Aids in Accurate Surgical Margin Detection for TURBO: A Case Report.Case Rep Oncol. 2018[citado 12 jun 2018]; 11(1):164–167. Disponible en: https://doi.org/10.1159/000487390

  29. Kubota Y, Nakaigawa N. Essential content of evidence‐based clinical practice guidelines for bladder cancer: the Japanese Urological Association 2015 update. Int J Urol. 2016[citado 12 jun 2017];23 (8):640–645. Disponible en: https://doi.org/10.1111/iju.13141

  30. Mossanen M, Gore JL. The burden of bladder cancer care: direct and indirect costs. Curr Opin Urol. 2014[citado 23 mar 2018]; 24 (5): 487– 491. Disponible en: https://journals.lww.com/courology/ Abstract/2014/09000/The_burden_of_bladder_cancer_care___direc t_and.11.aspx

  31. Oliva Encina J, Rioja Sanz C. Diagnóstico fotodinámico (PDD) en el cáncer vesical no músculo-invasivo. Revisión bibliográfica.Actas Urol Españolas. 2009 [citado 23 mar 2018]; 33(9): 965-975. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210- 48062009000900007&lng=es

  32. Mari A, Abufaraj M, Gust KM, Shariat SF. Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literature. Curr Opin Urol. 2018[citado 20 jun 2017]; 28(2):214-218. Disponible en: https://journals.lww.com/courology/ Fulltext/2018/03000/Novel_endoscopic_visualization_technique s_for.19.aspx




2020     |     www.medigraphic.com